AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Ambarella, you need to believe its edge AI platform can turn growing design wins into a more diversified, less consumer-dependent revenue base while moving toward better earnings quality. The Hanwha agreement looks supportive for this thesis, but the biggest near term catalyst and risk remain the same: execution in scaling higher margin edge AI SoCs against intense competition, while still carrying meaningful dependence on IoT and a few large customers.
The Hanwha deal connects directly to Ambarella’s earlier announcement of its CES-launched CV7 edge AI vision SoC, which targets high performance cameras, robotics, and edge infrastructure. Together, CV7 and the Hanwha partnership highlight how Ambarella is trying to lean into higher value enterprise and industrial use cases, an area many analysts already viewed as a key driver of future edge AI adoption and a potential offset to the cyclicality and concentration risk in its existing IoT revenue.
Yet against this promising backdrop, investors should still weigh how concentrated exposure to WT Microelectronics could...
Read the full narrative on Ambarella (it's free!)
Ambarella's narrative projects $526.3 million revenue and $74.3 million earnings by 2028.
Uncover how Ambarella's forecasts yield a $97.45 fair value, a 36% upside to its current price.
Some of the most optimistic analysts were already modeling revenue climbing toward about US$650.0 million with a sharp earnings swing, so this Hanwha news could either reinforce or challenge that view depending on how you think about customer concentration and execution risk.
Explore 6 other fair value estimates on Ambarella - why the stock might be worth as much as 65% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com